Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 16144913
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling.

  2003cited by this paper
• Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells.

  2002cited by this paper
• Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.

  2001cited by this paper
• Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.

  2001cited by this paper
• Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN.

  2001cited by this paper
• Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

  2000cited by this paper
• Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists

  2000cited by this paper
• Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.

  2000cited by this paper
• Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer.

  2000cited by this paper
• The multiple roles of PTEN in tumor suppression.

  2000cited by this paper
• Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase

  2000cited by this paper
• Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells.

  1999cited by this paper
• New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.

  1999cited by this paper
• PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function.

  1999cited by this paper
• Cellular survival: a play in three Akts.

  1999cited by this paper
• Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer.

  1999cited by this paper
• A Non-Radioactive Method for Inexpensive Quantitative RT-PCR

  1999cited by this paper
• Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.

  1998cited by this paper
• Recent advances in breast cancer biology

  1998cited by this paper
• Differentiation and reversal of malignant changes in colon cancer through PPARγ

  1998cited by this paper
• Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation.

  1998cited by this paper
• Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice.

  1998cited by this paper
• Terminal differentiation of human breast cancer through PPAR gamma.

  1998cited by this paper
• Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor.

  1997cited by this paper
• Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

  1997cited by this paper
• Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells.

  1996cited by this paper
• Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.

  1996cited by this paper
• Retinoid X receptor beta and peroxisome proliferator-activated receptor activate an estrogen response element.

  1995cited by this paper
• Steroid Hormone Antagonists Summary and Future Challenges

  1995cited by this paper
• Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements.

  1995cited by this paper
• The nuclear receptor superfamily: the second decade.

  1995cited by this paper
• Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor.

  1994cited by this paper
• Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.

  1994cited by this paper
• Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators.

  1994cited by this paper
• Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival.

  1994cited by this paper
• mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.

  1994cited by this paper
• Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription.

  1994cited by this paper
• Mechanisms of transactivation by retinoic acid receptors

  1993cited by this paper
• Steroid and related receptors.

  1993cited by this paper
• The retinoid X receptor enhances the function of the peroxisome proliferator activated receptor.

  1993cited by this paper
• Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

  1992cited by this paper
• Cross-coupling of signal transduction pathways: zinc finger meets leucine zipper.

  1991cited by this paper
• A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.

  1991cited by this paper
• Regulatory crosstalk at composite response elements.

  1991cited by this paper
• Synergistic transcriptional activation by CTF/NF-I and the estrogen receptor involves stabilized interactions with a limiting target factor

  1991cited by this paper
• The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties.

  1989cited by this paper
• The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate.

  1988cited by this paper
• Many transcription factors interact synergistically with steroid receptors.

  1988cited by this paper
• The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements.

  1988cited by this paper

• Clostridium butyricum alleviates multiple myeloma by remodeling the bone marrow microenvironment and inhibiting PI3K/AKT pathway through the gut‒bone axis

  2026cites this paper
• Hepatocyte ERα orchestrates sex-specific liver adaptation to fasting and feeding states

  2025cites this paper
• Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds

  2025cites this paper
• Klotho-gonadal hormone crosstalk in male and female reproduction.

  2025cites this paper
• Analysis of an adult diabetes mellitus caused by a rare mutation of the gene: A case report

  2024cites this paper
• Prelude to Malignancy: A Gene Expression Signature in Normal Mammary Gland from Breast Cancer Patients Suggests Pre-tumorous Alterations and Is Associated with Adverse Outcomes

  2024cites this paper
• A Multifunctional Therapeutic Strategy Using P7C3 as A Countermeasure Against Bone Loss and Fragility in An Ovariectomized Rat Model of Postmenopausal Osteoporosis

  2024cites this paper
• Effects of metal oxide inhalation on the transcription of some hormone receptors in the brain, examined in an in vivo mouse model

  2024cites this paper
• The regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets

  2023cites this paper
• PPARγ activation by fisetin mitigates vascular smooth muscle cell senescence via the mTORC2-FoxO3a-autophagy signaling pathway.

  2023cites this paper
• Targeting HMG-CoA synthase 2 suppresses tamoxifen-resistant breast cancer growth by augmenting mitochondrial oxidative stress-mediated cell death.

  2023cites this paper
• Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer

  2022cites this paper
• A novel chemo-phenotypic method identifies mixtures of salpn, vitamin D3, and pesticides involved in the development of colorectal and pancreatic cancer

  2022cites this paper
• The Role of PPARs in Breast Cancer

  2022cites this paper
• Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines

  2022cites this paper
• The Regulation of Adipose Tissue Health by Estrogens

  2022cites this paper
• Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy

  2022cites this paper
• Expression of pepsinogen A (PGA/PG I) in breast cancer and non-cancer tissues and its relationship with clinicopathological parameters of breast cancer

  2022cites this paper
• Troglitazone-Induced PRODH/POX-Dependent Apoptosis Occurs in the Absence of Estradiol or ERβ in ER-Negative Breast Cancer Cells

  2021cites this paper
• Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers

  2021cites this paper
• Estrogen and Glycemic Homeostasis: The Fundamental Role of Nuclear Estrogen Receptors ESR1/ESR2 in Glucose Transporter GLUT4 Regulation

  2021cites this paper
• Collagen metabolism as a regulator of proline dehydrogenase/proline oxidase-dependent apoptosis/autophagy

  2021cites this paper
• Paternal trans‐fatty acid and vitamin E diet affects rat offspring's semen quality and PPARs expression

  2021cites this paper
• Whole transcriptome RNA-seq reveals key regulatory factors involved in type 2 diabetes pathology in peripheral fat of Asian Indians

  2021cites this paper
• Methylation-Mediated Silencing of RBP7 Promotes Breast Cancer Progression through PPAR and PI3K/AKT Pathway

  2021cites this paper
• PPARgamma: A Potential Intrinsic and Extrinsic Molecular Target for Breast Cancer Therapy

  2021cites this paper
• Nuclear Receptors in Myocardial and Cerebral Ischemia—Mechanisms of Action and Therapeutic Strategies

  2021cites this paper
• Genetics and Clinical Characteristics of PPARγ Variant-Induced Diabetes in a Chinese Han Population

  2021cites this paper
• TLX, an orphan nuclear receptor with emerging roles in physiology and disease.

  2021cites this paper
• Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma

  2021cites this paper
• Evolution of non-genomic nuclear receptor function.

  2021cites this paper
• Acute inflammatory profiles differ with sex and age after spinal cord injury

  2021cites this paper
• Cancer prevention by different forms of tocopherols.

  2020cites this paper
• Natural and Synthetic PPARγ Ligands in Tumor Microenvironment: A New Potential Strategy against Breast Cancer

  2020cites this paper
• The Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical Studies

  2020cites this paper
• Peroxisome proliferator-activated receptor gamma expression along the male genital system and its role in male fertility.

  2020cites this paper
• Considerations for Studying Sex as a Biological Variable in Spinal Cord Injury

  2020cites this paper
• Nuclear Receptors Are Differentially Expressed and Activated in KAIMRC1 Compared to MCF7 and MDA-MB231 Breast Cancer Cells

  2019cites this paper
• Regulation of PTEN/AKT/FAK pathways by PPARγ impacts on fibrosis in diabetic nephropathy

  2019cites this paper
• Gene-gene and gene-environment interactions in lipodystrophy: Lessons learned from natural PPARγ mutants.

  2019cites this paper
• PTEN/PTENP1: ‘Regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy

  2018cites this paper
• Bisphenol A and its derivatives decrease expression of chemerin, which reverses its stimulatory action in ovarian cancer cells.

  2018cites this paper
• Flavonoids as putative modulators of &Dgr;4‐, &Dgr;5‐, and &Dgr;6‐desaturases: Studies in cultured hepatocytes, myocytes, and adipocytes

  2018cites this paper
• Thiazolidinedione therapy and breast cancer risk in diabetic women: A systematic review and meta‐analysis

  2018cites this paper
• Astragalus root induces ovarian β‑oxidation and suppresses estrogen‑dependent uterine proliferation.

  2018influential citation
• Targeting Peroxisome Proliferator-Activated Receptor γ to Increase Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer Cells

  2018cites this paper
• PPARs as determinants of the estrogen receptor lineage: use of synthetic lethality for the treatment of estrogen receptor-negative breast cancer.

  2017cites this paper
• PPAR g Ligand – induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers

  2017cites this paper
• Cancer cell line specific co-factors modulate the FOXM1 cistrome

  2017cites this paper
• Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) as a Target for Concurrent Management of Diabetes and Obesity-Related Cancer.

  2017cites this paper
• PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers

  2017cites this paper
• Bazedoxifene and raloxifene protect neocortical neurons undergoing hypoxia via targeting ERα and PPAR-γ.

  2017cites this paper
• PPARs as determinants of the estrogen receptor lineage: use of synthetic lethality for the treatment of estrogen receptor-negative breast cancer

  2017cites this paper
• Mediating Roles of PPARs in the Effects of Environmental Chemicals on Sex Steroids

  2017cites this paper
• PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers.

  2017cites this paper
• Unliganded estrogen receptor alpha regulates vascular cell function and gene expression.

  2017cites this paper
• Regulation of the tumor suppressor PTEN by natural anticancer compounds

  2017cites this paper
• Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression

  2016cites this paper
• Prenatal Exposures to Multiple Thyroid Hormone Disruptors: Effects on Glucose and Lipid Metabolism

  2016influential citation
• Peroxisome proliferator-activated receptors (PPARα, PPARγ and PPARβ/δ) gene expression profile on ram spermatozoa and their relation to the sperm motility

  2016cites this paper
• PPAR Agonists: I. Role of Receptor Subunits in Alcohol Consumption in Male and Female Mice.

  2016cites this paper
• TRIM24 orchestrates metabolic reprogramming and EMT in Breast Cancer

  2016cites this paper
• Trends in Breast Cancer Prevention

  2016cites this paper
• Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.

  2016cites this paper
• Peroxisome proliferator-activated receptor gamma (PPARγ) in brown trout: Interference of estrogenic and androgenic inputs in primary hepatocytes.

  2016cites this paper
• PPARγ and Its Ligands: Potential Antitumor Agents in the Digestive System.

  2016cites this paper
• Combination of Antiestrogens and Omega-3 Fatty Acids for Breast Cancer Prevention

  2015cites this paper
• Prognostic role of PPAR-γ and PTEN in the renal cell carcinoma.

  2015cites this paper
• Intracellular receptor regulation of adipose metabolism by the isoflavone genistein

  2015cites this paper
• Omega-3 DHA- and EPA-dopamine conjugates induce PPARγ-dependent breast cancer cell death through autophagy and apoptosis.

  2015cites this paper
• Gene expression of estrogen receptor-alpha in orbital fibroblasts in Graves' ophthalmopathy.

  2015cites this paper
• Peroxisome proliferator-activated receptor gamma signaling in human sperm physiology

  2015cites this paper
• Soy and the soy isoflavone genistein promote adipose tissue development in male mice on a low-fat diet

  2015cites this paper
• Differential roles of PPARγ vs TR4 in prostate cancer and metabolic diseases.

  2014cites this paper
• Estrogen deficiency does not decrease the in vitro osteogenic potential of rat adipose-derived mesenchymal stem cells

  2014cites this paper
• Activation of liver X receptor enhances the proliferation and migration of endothelial progenitor cells and promotes vascular repair through PI3K/Akt/eNOS signaling pathway activation.

  2014cites this paper
• Positive and negative effects of glitazones in carcinogenesis: experimental models vs. clinical practice.

  2014cites this paper
• Dietary tocopherols inhibit cell proliferation, regulate expression of ERα, PPARγ, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia

  2013cites this paper
• Influence of 17β-estradiol on 15-deoxy-δ12,14 prostaglandin J2 -induced apoptosis in MCF-7 and MDA-MB-231 cells.

  2013cites this paper
• Cucurbitane Triterpenoid from Momordica charantia Induces Apoptosis and Autophagy in Breast Cancer Cells, in Part, through Peroxisome Proliferator-Activated Receptor γ Activation

  2013cites this paper
• Activation of estrogen receptors with E2 downregulates peroxisome proliferator-activated receptor γ in hepatocellular carcinoma.

  2013cites this paper
• Omega‐3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF‐7 breast cancer cells

  2013cites this paper
• Natural Products in Cancer Prevention and Therapy

  2013cites this paper
• Chemopreventive activity of tocopherols in mammary tumorigenesis

  2013influential citation
• The role of peroxisome proliferator-activated receptor-γ in breast cancer.

  2012cites this paper
• Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cells.

  2012cites this paper
• Dietary Administration of δ- and γ-Tocopherol Inhibits Tumorigenesis in the Animal Model of Estrogen Receptor–Positive, but not HER-2 Breast Cancer

  2012cites this paper
• TGF-β mediates suppression of adipogenesis by estradiol through connective tissue growth factor induction.

  2012cites this paper
• PPAR gamma, bioactive lipids, and cancer progression.

  2012cites this paper
• PPARγ Agonists Target Aromatase Via Both PGE2 and BRCA1

  2012cites this paper
• Effects of Omega-3 Fatty Acids on Progestin Stimulation of Invasive Properties in Breast Cancer

  2012cites this paper
• Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.

  2012cites this paper
• PPARγ antagonist GW9662 induces functional estrogen receptor in mouse mammary organ culture: potential translational significance

  2012cites this paper
• Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptorγ Enhances the Chemopreventive Effect of Anti-Estrogen

  2012cites this paper
• Dietary Administration of d- and g-Tocopherol Inhibits Tumorigenesis in the Animal Model of Estrogen Receptor– Positive, but not HER-2 Breast Cancer

  2012cites this paper
• In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancer.

  2011cites this paper
• Chemopreventive Activity of Vitamin E in Breast Cancer: A Focus on γ- and δ-Tocopherol

  2011cites this paper
• Skp2 is a Promising Therapeutic Target in Breast Cancer

  2011cites this paper
• Effects of fish oil and Tamoxifen on preneoplastic lesion development and biomarkers of oxidative stress in the early stages of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis.

  2011cites this paper
• Redox environment and its meaning for breast cancer cells fate.

  2011cites this paper